← Leaderboards
Robert M Aris
University Of North Carolina Chapel Hill
$1,353,796
Attributed
$1,353,796
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,353,796 · 3
By mechanism
M01$1,353,796 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Richard C Henderson$1,860,888
- Robert J Aris$0
- Thomas M. Egan$5,500,961
- Louis E Underwood$5,889,688
- John B Buse$71,388,050
Others in their field
Top investigators on “Cystic Fibrosis”
- John F Engelhardt · University Of Iowa$42,933,706
- Michael R Knowles · University Of North Carolina Chapel Hill$30,250,682
- David A Stoltz · University Of Iowa$25,455,359
- Joseph Zabner · University Of Iowa$25,382,103
- Paul B McCray · University Of Iowa$25,146,293
- Richard C Boucher · University Of North Carolina Chapel Hill$24,890,955
Research focus
Cystic FibrosisHuman Therapy EvaluationDrug Screening /EvaluationHuman SubjectClinical ResearchPhosphonateOsteoporosisSkeletal PharmacologySkeletal Disorder ChemotherapyBone DensityAlendronateBone MetabolismInhibitor /AntagonistMetabolism Disorder ChemotherapyOral AdministrationPhysiologic Bone ResorptionVitamin DPatient Oriented ResearchLung TransplantationDiphosphonateCalcium
Grant awards (8)
The Effects of Alendronate on Bone Metabolism in Patients with CF$1,415
M01 · FY2004 · RR
Bisphosphonates on Bone Mineral Density in Patients with Cystic Fibrosis$283
M01 · FY2004 · RR
PAMIDRONATE ON BONE DENSITY IN PATIENTS WITH CYSTIC FIBROSIS$190,747
M01 · FY2002 · RR
EFFECTS OF ALENDRONATE ON BONE METABOLISM IN PATIENTS WITH CYSTIC FIBROSIS$190,747
M01 · FY2002 · RR
PAMIDRONATE ON BONE DENSITY IN PATIENTS WITH CYSTIC FIBROSIS$294,555
M01 · FY2001 · RR
EFFECTS OF ALENDRONATE ON BONE METABOLISM IN PATIENTS WITH CYSTIC FIBROSIS$294,555
M01 · FY2001 · RR
PAMIDRONATE ON BONE DENSITY IN PATIENTS WITH CYSTIC FIBROSIS$190,747
M01 · FY2001 · RR
EFFECTS OF ALENDRONATE ON BONE METABOLISM IN PATIENTS WITH CYSTIC FIBROSIS$190,747
M01 · FY2001 · RR